HTGM - HTG shares surge after upbeat 2020 revenue forecast

HTG Molecular Diagnostics shares jump ([[HTGM]] +16.6%) after the company forecast revenue growth in 2021 and said that it expects total revenue for the full year of 2020 to be about $8.5M.The company said its cash, cash equivalents and short-term marketable securities are expected to be about $28.7M as of December 31, 2020.HTG said that its gene whole transcriptome product is in development and is on track to be launched in the third quarter of 2021.The company expects to announce full 2020 financial results in advance of its quarterly conference call in March 2021.

For further details see:

HTG shares surge after upbeat 2020 revenue forecast